ArticleCancer gene therapy2013

Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy.

E R Camp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.